focus -WSS

focus

author：Wikipedia 2025-09-30 13:44:30 - browse：986

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

WSS

Readout Newsletter: Amylyx, Aurinia, and IQVIA

UnitedHealth quietly bought dozens of outpatient centers

IVF, abortion rights issues kick off Biden’s State of the Union

Long Covid research funding gets a major boost from NIH

Congress might make insulin pumps more accessible to the blind

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

leisure time

focus

hotspot

Apple is now the first public company to be valued at $3 trillion

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Trump demands the U.S. pay no more for drugs than other countries … again

Amylyx ALS drug failure raises questions and concerns

Moonlake's readout produced a cash windfall. Risks remain

A deep dive into Applied Therapeutics’ data, and questions on Cassava

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Congress might make insulin pumps more accessible to the blind

Novavax promises a turnaround & Lilly roils the obesity market

Why don't Americans have at

entertainment

Air quality improving but still lags in Black, Hispanic communities

STAT Boddities: What happens to the brain when we get scared?

Report cites 'urgent' need to recruit more diverse clinical trial participants

Tome Biosciences co

Sen. Paul opposes bill to ban Chinese biotechs

Long Covid research funding gets a major boost from NIH

leisure time

focus

knowledge

focus